Search - tctmd.com

Displaying 41 - 60 of 296

Sort: Relevancy | Date

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

Presentation TVT 2023

The Case for ‘Default OAC’ in Valve-in-Valve TAVR – Pros and Cons

Presenter: Isaac George

June 08, 2023

Presentation TVT 2023

Case Resolution: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What

Presenter: Sachin Goel

June 08, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: Show Me the Data! Is HALT After TAVR Associated With Clinical Events or Accelerated SVD?

Presenter: Raj Makkar

June 08, 2023

Presentation TVT 2023

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

Presenter: Tarun Chakravarty

June 08, 2023

Presentation TVT 2023

Diagnosis, and Imaging Findings in HALT and THV Thrombosis (Workup of Elevated Gradients)

Presenter: Joao Cavalcante

June 08, 2023

Presentation TVT 2023

Case Presentation: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What?

Presenter: Sachin Goel

June 08, 2023

News Daily News

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

Todd Neale

June 05, 2023

News Features

Some Rays of Hope for ‘Sorry State’ of Transplant Rejection

Shelley Wood

May 08, 2023

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Conference News PCR London Valves 2022

Registry Results See Less PVL, Pacemakers With Acurate neo2

Shelley Wood

November 29, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Todd Neale

October 19, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Daily News

Another DOAC Fails in the Setting of Mechanical Heart Valves

Todd Neale

September 28, 2022

Presentation TCT 2022

Thrombosis, HALT, and Bleeding Risk

Presenter: Gagan D. Singh

September 19, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

Presentation TCT 2022

Pathology of Self-Expanding Transcatheter Aortic Valve Failure and Hypo-Attenuated Leaflet Thickening (HALT)

Presenter: Yu Sato

September 17, 2022

Presentation TCT 2022

HALT and HAM: Harmless Bystander or Long-Term Danger?

Presenter: Joao Cavalcante

September 17, 2022

Advertisement

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

The Case for ‘Default OAC’ in Valve-in-Valve TAVR – Pros and Cons

Case Resolution: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What

SPOTLIGHT LECTURE: Show Me the Data! Is HALT After TAVR Associated With Clinical Events or Accelerated SVD?

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

Diagnosis, and Imaging Findings in HALT and THV Thrombosis (Workup of Elevated Gradients)

Case Presentation: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What?

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

Some Rays of Hope for ‘Sorry State’ of Transplant Rejection

December 2022 News Roundup

Registry Results See Less PVL, Pacemakers With Acurate neo2

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Another DOAC Fails in the Setting of Mechanical Heart Valves

Thrombosis, HALT, and Bleeding Risk

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Pathology of Self-Expanding Transcatheter Aortic Valve Failure and Hypo-Attenuated Leaflet Thickening (HALT)

HALT and HAM: Harmless Bystander or Long-Term Danger?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content